Stay up to date with our latest news and events.
Proteos is committed to the health and safety of our employees, clients, and the community and will be taking actions to mitigate the risk of COVID-19 transmission. With the growing health concern, we will be restricting laboratory operations. This action may result in extended project timelines but will not negatively impact project quality or our availability to communicate via email or teleconference.
Proteos is committed to providing a quality foundation for drug discovery research. While we have a great deal of experience purifying untagged proteins, it is generally preferable to employ an affinity tag to facilitate purification and detection of the protein of interest.
We would like to thank our valued customers for your business and support in 2019.
As we continue to enhance the experience for our valued clients, we recently streamlined our processes for contacting members of our team and for requesting a quotation.
Factors to consider when selecting the optimal expression system for your protein of interest: structural complexity, post-translational modifications, solubility, cellular localization, and investment.
Proteos is proud to be partnered with The Michael J. Fox Foundation to provide standardized high-quality protein reagents for Parkinson’s disease research.
Founded by former scientists from the biopharma industry, Proteos is steadfastly committed to delivering the industry’s best recombinant protein expression services. Since 2003, we’ve worked to expand the services that we offer, improve our capabilities, and simplify the client experience. From increasing our production capabilities to launching our e-commerce website, our goal is to provide our customers with access to the recombinant protein production services that they need in an efficient, streamlined manner. In today’s post, we’re going to look at a few reasons why you should choose Proteos for your project.
On this day 16 years ago, Proteos was incorporated and began providing recombinant protein production services for discovery research.
Drug discovery can be unpredictable and requires flexibility to overcome unforeseen challenges. We continually examine whether projects are running as planned and quickly communicate if the unexpected happens – enabling us to change directions mid-project if needed.
Obtaining the highest quality recombinant proteins is critical to the advancement of your discovery program. Proteos has more that 15 years of experience producing a wide variety of recombinant proteins at the highest quality standards, to keep your program moving forward.
